BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29746922)

  • 21. Does Prior Cancer Have an Influence on the Survival Outcomes of Patients with Localized Pancreatic Neuroendocrine Tumors?
    Wang L; Li G; Bing YT; Tian ML; Wang HY; Yuan CH; Xiu DR
    Chin Med Sci J; 2021 Dec; 36(4):284-294. PubMed ID: 34986965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly Differentiated.
    Raj N; Valentino E; Capanu M; Tang LH; Basturk O; Untch BR; Allen PJ; Klimstra DS; Reidy-Lagunes D
    Pancreas; 2017 Mar; 46(3):296-301. PubMed ID: 27759713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex.
    Larson AM; Hedgire SS; Deshpande V; Stemmer-Rachamimov AO; Harisinghani MG; Ferrone CR; Shah U; Thiele EA
    Clin Genet; 2012 Dec; 82(6):558-63. PubMed ID: 22035404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours.
    Young K; Lawlor RT; Ragulan C; Patil Y; Mafficini A; Bersani S; Antonello D; Mansfield D; Cingarlini S; Landoni L; Pea A; Luchini C; Piredda L; Kannan N; Nyamundanda G; Morganstein D; Chau I; Wiedenmann B; Milella M; Melcher A; Cunningham D; Starling N; Scarpa A; Sadanandam A
    Gut; 2021 Oct; 70(10):1904-1913. PubMed ID: 32883872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EUS-guided FNA cytology of pancreatic neuroendocrine tumour (PanNET): a retrospective study of 132 cases over an 18-year period in a single institution.
    Chen S; Lin J; Wang X; Wu HH; Cramer H
    Cytopathology; 2014 Dec; 25(6):396-403. PubMed ID: 24635775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The bidirectional interation between pancreatic cancer and diabetes.
    Li J; Cao G; Ma Q; Liu H; Li W; Han L
    World J Surg Oncol; 2012 Aug; 10():171. PubMed ID: 22920886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.
    de Wilde RF; Edil BH; Hruban RH; Maitra A
    Nat Rev Gastroenterol Hepatol; 2012 Feb; 9(4):199-208. PubMed ID: 22310917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors.
    Park JK; Paik WH; Lee K; Ryu JK; Lee SH; Kim YT
    Oncotarget; 2017 Jul; 8(30):49796-49806. PubMed ID: 28591701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An overview of pancreatic neuroendocrine tumours.
    Burgess A
    Nurs Stand; 2008 Oct 29-Nov 4; 23(8):35-40. PubMed ID: 18986079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.
    Farrell JM; Pang JC; Kim GE; Tabatabai ZL
    Cancer Cytopathol; 2014 Oct; 122(10):770-8. PubMed ID: 25044931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review.
    Maiorano BA; Schinzari G; Chiloiro S; Visconti F; Milardi D; Bianchi A
    Protein Pept Lett; 2020; 27(12):1276-1287. PubMed ID: 31804164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival.
    Kim JY; Brosnan-Cashman JA; An S; Kim SJ; Song KB; Kim MS; Kim MJ; Hwang DW; Meeker AK; Yu E; Kim SC; Hruban RH; Heaphy CM; Hong SM
    Clin Cancer Res; 2017 Mar; 23(6):1598-1606. PubMed ID: 27663587
    [No Abstract]   [Full Text] [Related]  

  • 33. Systemic Treatment Selection for Patients with Advanced Pancreatic Neuroendocrine Tumours (PanNETs).
    Megdanova-Chipeva VG; Lamarca A; Backen A; McNamara MG; Barriuso J; Sergieva S; Gocheva L; Mansoor W; Manoharan P; Valle JW
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study.
    Tong Z; Liu L; Zheng Y; Jiang W; Zhao P; Fang W; Wang W
    World J Surg Oncol; 2017 May; 15(1):108. PubMed ID: 28558772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes and pancreatic cancer: chicken or egg?
    Magruder JT; Elahi D; Andersen DK
    Pancreas; 2011 Apr; 40(3):339-51. PubMed ID: 21412116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs).
    Partelli S; Gaujoux S; Boninsegna L; Cherif R; Crippa S; Couvelard A; Scarpa A; Ruszniewski P; Sauvanet A; Falconi M
    JAMA Surg; 2013 Oct; 148(10):932-9. PubMed ID: 23986355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystic pancreatic neuroendocrine tumors: a clinicopathologic study.
    Singhi AD; Chu LC; Tatsas AD; Shi C; Ellison TA; Fishman EK; Kawamoto S; Schulick RD; Wolfgang CL; Hruban RH; Edil BH
    Am J Surg Pathol; 2012 Nov; 36(11):1666-73. PubMed ID: 23073325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimodality Management of "Borderline Resectable" Pancreatic Neuroendocrine Tumors: Report of a Single-Institution Experience.
    Ambe CM; Nguyen P; Centeno BA; Choi J; Strosberg J; Kvols L; Hodul P; Hoffe S; Malafa MP
    Cancer Control; 2017; 24(5):1073274817729076. PubMed ID: 28975822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients.
    Gong Y; Fan Z; Luo G; Huang Q; Qian Y; Cheng H; Jin K; Ni Q; Yu X; Liu C
    Cancer Manag Res; 2020; 12():6727-6737. PubMed ID: 32848455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.
    Ramage JK; Davies AH; Ardill J; Bax N; Caplin M; Grossman A; Hawkins R; McNicol AM; Reed N; Sutton R; Thakker R; Aylwin S; Breen D; Britton K; Buchanan K; Corrie P; Gillams A; Lewington V; McCance D; Meeran K; Watkinson A;
    Gut; 2005 Jun; 54 Suppl 4(Suppl 4):iv1-16. PubMed ID: 15888809
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.